Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000904454-04-000370
Filing Date
2004-05-26
Accepted
2004-05-26 18:48:49
Documents
1
Period of Report
2004-05-26

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 3  
1 PRIMARY DOCUMENT edgar.xml 3 5483
  Complete submission text file 0000904454-04-000370.txt   7504
Mailing Address
Business Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933 7325242454
JOHNSON & JOHNSON (Reporting) CIK: 0000200406 (see all company filings)

State of Incorp.: NJ | Fiscal Year End: 0103
Type: 3 | Act: 34 | File No.: 000-50767 | Film No.: 04833354
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address
JOHNSON & JOHNSON DEVELOPMENT CORP ET AL (Reporting) CIK: 0000924020 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-50767 | Film No.: 04833353

Mailing Address
Business Address 675 MASSACHUSETTS AVE 14TH FLOOR CAMBRIDGE MA 02139 6173549311
CRITICAL THERAPEUTICS INC (Issuer) CIK: 0001145404 (see all company filings)

EIN.: 043523569 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations